Pfizer (PFE)
24.87
-0.07 (0.28%)
Upcoming Events
Latest Headlines
Form 4 PFIZER INC For: Jul 15 Filed by: BOURLA ALBERT
July 16, 2026 6:18 PM - SEC Filing
Pfizer temporarily discontinues premarin vaginal cream in India, citing supply challenges - Reuters
July 16, 2026 1:35 PM - StreetInsider
Form 4 PFIZER INC For: Jul 09 Filed by: BOURLA ALBERT
July 13, 2026 3:43 PM - SEC Filing
Pfizer (PFE) PT Lowered to $30 at BMO Capital
July 13, 2026 7:37 AM - StreetInsider
Pfizer (PFE) PT Lowered to $35 at Guggenheim
July 13, 2026 6:51 AM - StreetInsider
FDA approves Padcev plus Keytruda for muscle-invasive bladder cancer
July 10, 2026 11:23 AM - StreetInsider
U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
July 10, 2026 11:23 AM - BizWire
Pfizer (PFE) PT Lowered to $28 at JPMorgan
July 8, 2026 7:05 AM - StreetInsider
HSBC Downgrades Pfizer (PFE) to Hold
July 6, 2026 1:35 AM - StreetInsider
Form 4 PFIZER INC For: Jun 30 Filed by: BOURLA ALBERT
July 1, 2026 3:50 PM - SEC Filing
Form 4 PFIZER INC For: Jun 26 Filed by: Buckley Mortimer J
June 30, 2026 3:19 PM - SEC Filing
Form 4 PFIZER INC For: Jun 26 Filed by: Echevarria Joseph
June 30, 2026 3:19 PM - SEC Filing
Form 4 PFIZER INC For: Jun 26 Filed by: NARAYEN SHANTANU
June 30, 2026 3:17 PM - SEC Filing
Form 4 PFIZER INC For: Jun 26 Filed by: SMITH JAMES C
June 30, 2026 3:11 PM - SEC Filing
Form 4 PFIZER INC For: Jun 26 Filed by: Quincey James
June 30, 2026 3:10 PM - SEC Filing
Form 4 PFIZER INC For: Jun 26 Filed by: Taraporevala Cyrus
June 30, 2026 3:09 PM - SEC Filing
Pfizer Declares Third-Quarter 2026 Dividend
June 24, 2026 3:52 PM - BizWire
Pfizer (PFE) Declares $0.43 Quarterly Dividend; 7.1% Yield
June 24, 2026 3:52 PM - StreetInsider
FDA approves Pfizer's Ibrance for HR+, HER2+ metastatic breast cancer
June 24, 2026 2:10 PM - StreetInsider
FDA Approves Pfizer’s IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance
June 24, 2026 2:10 PM - BizWire
FDA: approves Pfizer's palbociclib (ibrance) with trastuzumab for HR-positive, her2-positive metastatic breast cancer
June 24, 2026 11:42 AM - StreetInsider
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
June 24, 2026 8:30 AM - StreetInsider
Enanta Pharma loses appeal in Pfizer Paxlovid patent case
June 23, 2026 5:30 PM - StreetInsider
Pfizer executive says China now leads Europe in drug innovation
June 23, 2026 12:15 PM - StreetInsider
Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts
June 23, 2026 10:00 AM - BizWire
BMO Capital on Pfizer (PFE): 'SigVie Trial Misses on OS With Signs of Benefit for Future Trials'
June 23, 2026 8:44 AM - StreetInsider
Pfizer (PFE) Reiterated at Neutral by Cantor Fitzgerald on Negative SV Data
June 23, 2026 7:24 AM - StreetInsider
Pfizer lung cancer drug misses survival goal in Phase 3 trial
June 22, 2026 4:30 PM - StreetInsider
Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
June 22, 2026 4:30 PM - BizWire
Pfizer reafffirms 2026 guidance after CFO transition announcement
June 18, 2026 1:24 PM - StreetInsider
Pfizer reaffirms 2026 guidance after CFO transition news
June 18, 2026 1:18 PM - StreetInsider
Form 8-K PFIZER INC For: Jun 18
June 18, 2026 1:17 PM - SEC Filing
FreeCast surges premarket; Accenture, Novocure slide
June 18, 2026 8:02 AM - StreetInsider
Form 8-K PFIZER INC For: Jun 18
June 18, 2026 7:07 AM - SEC Filing
Pfizer CFO Dave Denton to leave for consumer goods role
June 18, 2026 6:45 AM - StreetInsider
Pfizer Announces Chief Financial Officer Transition
June 18, 2026 6:45 AM - BizWire
Arvinas and Pfizer complete Rigel license deal for vepdegestrant
June 16, 2026 4:33 PM - StreetInsider
Form 4 PFIZER INC For: Jun 15 Filed by: BOURLA ALBERT
June 16, 2026 4:21 PM - SEC Filing
Form 11-K PFIZER INC For: Dec 31
June 16, 2026 4:02 PM - SEC Filing
Form 11-K PFIZER INC For: Dec 31
June 16, 2026 3:49 PM - SEC Filing
German government to drop variable drug discounting plans - Reuters
June 15, 2026 6:08 AM - StreetInsider
Form 4 PFIZER INC For: Jun 09 Filed by: DAMICO JENNIFER B.
June 10, 2026 7:58 PM - SEC Filing
Pfizer upgraded by RBC as valuation resets ahead of key pipeline catalysts
June 10, 2026 3:50 PM - StreetInsider
RBC Capital Upgrades Pfizer (PFE) to Sector Perform
June 10, 2026 2:29 AM - StreetInsider
Cancer's Toughest Targets Are Drawing Wall Street's Attention as Oncology Innovation Accelerates
June 9, 2026 9:44 AM - StreetInsider
FDA approves expanded HYMPAVZI use for hemophilia patients with inhibitors
June 8, 2026 6:45 AM - StreetInsider
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need
June 8, 2026 6:45 AM - BizWire
Pfizer targets obesity market with monthly weight-loss injection data
June 6, 2026 6:03 PM - StreetInsider
Pfizer reports phase 2b results for monthly obesity drug berobenatide
June 6, 2026 9:00 AM - StreetInsider
Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA Berobenatide
June 6, 2026 9:00 AM - BizWire
ADA 2026 preview: All eyes on these 2 stocks
June 4, 2026 7:00 PM - StreetInsider
Form 4 PFIZER INC For: May 29 Filed by: BOURLA ALBERT
June 1, 2026 7:42 PM - SEC Filing
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
June 1, 2026 10:00 AM - BizWire
Lilly’s Cancer Bombshell Sparks Hunt for the Next Oncology Stock Set to Explode
June 1, 2026 9:05 AM - StreetInsider
Pfizer (PFE) Reiterates at Neutral by Cantor Fitzgerald
June 1, 2026 8:02 AM - StreetInsider
Pfizer drug combination cuts prostate cancer progression risk by 52%
June 1, 2026 2:54 AM - StreetInsider
Pfizer's BRAFTOVI regimen shows improved survival in colorectal cancer
June 1, 2026 2:53 AM - StreetInsider
Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer
May 31, 2026 8:00 AM - BizWire
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
May 30, 2026 8:00 AM - BizWire
Morgan Stanley: China healthcare sector dips 1.3% amid licensing scrutiny
May 29, 2026 12:07 PM - StreetInsider
Pfizer's LORBRENA shows 55% seven-year survival without progression
May 29, 2026 8:02 AM - StreetInsider
Seven-Year Analysis from Pfizer’s LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer
May 29, 2026 8:00 AM - BizWire
Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
May 28, 2026 7:00 PM - BizWire
Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
May 28, 2026 7:00 PM - PR NewsWire
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
May 27, 2026 10:00 AM - BizWire
UBS Reiterates Neutral Rating on Pfizer (PFE)
May 27, 2026 9:46 AM - StreetInsider
Pfizer starts phase 3 trial for pediatric pneumococcal vaccine
May 20, 2026 5:05 AM - StreetInsider
Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results
May 20, 2026 5:05 AM - BizWire
Form 4 PFIZER INC For: May 15 Filed by: BOURLA ALBERT
May 18, 2026 4:39 PM - SEC Filing
Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026
May 18, 2026 8:01 AM - PR NewsWire
Arvinas Inc. (ARVN) PT Raised to $16 at BofA Securities
May 13, 2026 2:53 PM - StreetInsider
European Commission approves Pfizer's HYMPAVZI for hemophilia with inhibitors
May 13, 2026 6:45 AM - StreetInsider
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors
May 13, 2026 6:45 AM - BizWire
Form 13F-HR PFIZER INC For: Mar 31
May 12, 2026 4:52 PM - SEC Filing
FDA Commissioner Marty Makary to step down - Politico
May 12, 2026 12:52 PM - StreetInsider
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
May 12, 2026 9:00 AM - StreetInsider
Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)
May 12, 2026 7:01 AM - StreetInsider
Arvinas and Pfizer sell VEPPANU rights to Rigel for $85 million upfront
May 12, 2026 7:01 AM - StreetInsider
Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)
May 12, 2026 7:00 AM - Globe NewsWire
MBX Biosciences (MBX) PT Raised to $86 at Citizens on 'Good' MBX 4291 Update
May 12, 2026 5:37 AM - StreetInsider
HHS downplays Hantavirus risk amid repatriation efforts
May 11, 2026 10:23 AM - StreetInsider
The Next Generation of the GLP-1 Revolution Is Already Underway
May 11, 2026 8:30 AM - Globe NewsWire
Health officials explore restrictions on certain SSRI antidepressants - Reuters
May 8, 2026 12:04 PM - StreetInsider
Novo Nordisk Eyes Large-Scale M&A Following Pfizer's Metsera Win - Semafor
May 7, 2026 2:15 PM - StreetInsider
Form S-8 PFIZER INC
May 5, 2026 4:42 PM - SEC Filing
Pfizer (PFE) PT Raised to $27 at BofA Securities
May 5, 2026 3:11 PM - StreetInsider
Pfizer Reviewing New Molecule It Designed Using AI - CEO
May 5, 2026 2:11 PM - StreetInsider
Pfizer beats first quarter estimates on strong product growth
May 5, 2026 7:17 AM - StreetInsider
Form 10-Q PFIZER INC For: Mar 29
May 5, 2026 7:03 AM - SEC Filing
Form 8-K PFIZER INC For: May 05
May 5, 2026 7:01 AM - SEC Filing
Pfizer (PFE) Tops Q1 EPS by 3c, Beats on Revenue; Offers FY26 EPS Guidance
May 5, 2026 6:46 AM - StreetInsider
Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance
May 5, 2026 6:45 AM - BizWire
Form 4 PFIZER INC For: Apr 30 Filed by: BOURLA ALBERT
May 4, 2026 4:20 PM - SEC Filing
Pfizer (PFE) call put ratio 4.7 calls to 1 put quarter results
May 4, 2026 11:18 AM - StreetInsider
Pfizer (PFE) calls more active than puts into quarter results
May 4, 2026 5:38 AM - StreetInsider
FDA approves first PROTAC therapy VEPPANU for breast cancer
May 1, 2026 12:43 PM - StreetInsider
Form SCHEDULE 13G PFIZER INC Filed by: VANGUARD CAPITAL MANAGEMENT LLC
May 1, 2026 11:53 AM - SEC Filing
Pfizer (PFE) call put ratio 2.9 calls to 1 put with a focus on May 8 weekly 27 calls into quarter results
May 1, 2026 10:50 AM - StreetInsider
Pfizer's ELREXFIO meets primary endpoint in multiple myeloma trial
April 29, 2026 6:45 AM - StreetInsider
Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma
April 29, 2026 6:45 AM - BizWire
Raymond James on BridgeBio Pharma (BBIO): 'We expect continued strong commercial momentum for Attruby'
April 28, 2026 2:00 PM - StreetInsider
Barclays on BridgeBio Pharma (BBIO): 'We see buying opportunity on weakness, reiterate top idea'
April 28, 2026 12:14 PM - StreetInsider
TD Cowen on BridgeBio Pharma (BBIO): 'A key overhang is removed now'
April 28, 2026 11:46 AM - StreetInsider
RBC Capital on BridgeBio Pharma (BBIO): 'we remain buyers'
April 28, 2026 11:41 AM - StreetInsider
Mizuho on BridgeBio Pharma (BBIO): 'Not Best Case but Still Good Outcome Relative to Street'
April 28, 2026 11:25 AM - StreetInsider
Morgan Stanley on Pfizer (PFE): 'we believe generic versions of Vyndaqel could still represent a potential headwind to the franchise'
April 28, 2026 10:53 AM - StreetInsider
Pfizer extends VYNDAMAX patent protection to 2031 through settlements
April 28, 2026 10:17 AM - StreetInsider
Pfizer Reaches Three Settlement Agreements for VYNDAMAX
April 28, 2026 10:17 AM - BizWire
Mizuho: 'BBIO could potentially trade in the $90-110+ range today / near-term'
April 28, 2026 9:48 AM - StreetInsider
RBC on Pfizer (PFE): 'Litigation overhang cleared'
April 28, 2026 9:46 AM - StreetInsider
Barclays: 'We think dropping the question of '441 validity from the case is a major development'
April 28, 2026 9:38 AM - StreetInsider
Form 4 PFIZER INC For: Apr 23 Filed by: Gottlieb Scott
April 27, 2026 6:40 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: LITTMAN DAN R.
April 27, 2026 6:40 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: NORA JOHNSON SUZANNE M
April 27, 2026 6:40 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: Desmond-Hellmann Susan
April 27, 2026 6:38 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: Buckley Mortimer J
April 27, 2026 6:38 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: BLAYLOCK RONALD E
April 27, 2026 6:38 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: Echevarria Joseph
April 27, 2026 6:38 PM - SEC Filing
Form 3/A PFIZER INC For: Apr 01 Filed by: Hancock Dennis P
April 27, 2026 6:24 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: NARAYEN SHANTANU
April 27, 2026 6:24 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: SMITH JAMES C
April 27, 2026 6:22 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: Quincey James
April 27, 2026 6:22 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: Taraporevala Cyrus
April 27, 2026 6:22 PM - SEC Filing
Form 8-K PFIZER INC For: Apr 23
April 27, 2026 5:18 PM - SEC Filing
Bristol Myers Squibb and Pfizer partner with Mark Cuban's Cost Plus Drugs
April 24, 2026 6:59 AM - StreetInsider
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company
April 24, 2026 6:59 AM - BizWire
Full Article List
